PL2948156T3 - Zastosowanie soli wolframu (vi) w leczeniu niepłodności żeńskiej u nie chorujących na cukrzycę ssaków - Google Patents

Zastosowanie soli wolframu (vi) w leczeniu niepłodności żeńskiej u nie chorujących na cukrzycę ssaków

Info

Publication number: PL2948156T3
Authority: PL; Poland
Prior art keywords: mammarian; wolfram; don; disease; salt
Prior art date: 2013-01-22

Application number

PL14701067T

Other languages

English (en)

Inventor

Almazán Ignacio Canals

Bugié Agnès Arbat

Original Assignee

Oxolife Sl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-01-22

Filing date

2014-01-21

Publication date

2017-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49999950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2948156(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-01-21 Application filed by Oxolife Sl filed Critical Oxolife Sl

2017-07-31 Publication of PL2948156T3 publication Critical patent/PL2948156T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Hematology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Physiology (AREA)

PL14701067T 2013-01-22 2014-01-21 Zastosowanie soli wolframu (vi) w leczeniu niepłodności żeńskiej u nie chorujących na cukrzycę ssaków PL2948156T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES201330071A ES2478790B1 (es)	2013-01-22	2013-01-22	Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
EP14701067.2A EP2948156B1 (en)	2013-01-22	2014-01-21	Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals

Publications (1)

Publication Number	Publication Date
PL2948156T3 true PL2948156T3 (pl)	2017-07-31

Family

ID=49999950

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14701067T PL2948156T3 (pl)	2013-01-22	2014-01-21	Zastosowanie soli wolframu (vi) w leczeniu niepłodności żeńskiej u nie chorujących na cukrzycę ssaków

Country Status (26)

Country	Link
US (1)	US9675638B2 (pl)
EP (1)	EP2948156B1 (pl)
JP (1)	JP6045721B2 (pl)
KR (1)	KR102182563B1 (pl)
CN (1)	CN105188721B (pl)
AU (1)	AU2014209987B2 (pl)
BR (1)	BR112015017483A2 (pl)
CA (1)	CA2898953C (pl)
CL (1)	CL2015002047A1 (pl)
CY (1)	CY1118287T1 (pl)
DK (1)	DK2948156T3 (pl)
ES (2)	ES2478790B1 (pl)
HR (1)	HRP20161611T1 (pl)
HU (1)	HUE031910T2 (pl)
IL (1)	IL240062B (pl)
LT (1)	LT2948156T (pl)
MX (1)	MX356851B (pl)
NZ (1)	NZ710583A (pl)
PL (1)	PL2948156T3 (pl)
PT (1)	PT2948156T (pl)
RS (1)	RS55418B1 (pl)
RU (1)	RU2635507C2 (pl)
SG (1)	SG11201505701WA (pl)
SI (1)	SI2948156T1 (pl)
SM (2)	SMT201700018T1 (pl)
WO (1)	WO2014114644A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2551828B1 (es) *	2014-05-21	2016-09-12	Oxolife S.L.	Composiciones alimentarias que comprenden sales de tungsteno (VI)
ES2639588B1 (es) *	2014-05-21	2018-09-06	Oxolife, S.L.	Uso de una sal de tungsteno (VI) para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético
SI3173382T1 (sl) *	2014-07-21	2023-04-28	Oxolife, S. L.	Volframove (VI) soli za stimuliranje plodnosti in reprodukcije ter za izboljšanje učinkovitosti tehnik asistirane reprodukcije
EP4368577A1 (en) *	2022-11-08	2024-05-15	Oxolife, S.L.	Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4328134A (en) *	1980-05-06	1982-05-04	Schally Andrew Victor	Anorexigenic peptides
ES2108642B1 (es) *	1995-07-26	1998-08-16	Quimica Farm Bayer Sa	Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2141361C1 (ru) *	1998-03-12	1999-11-20	Пермская государственная медицинская академия	Способ лечения ановуляторного бесплодия при ожирении
ES2187276B1 (es) *	2001-05-16	2004-08-01	Quimica Farmaceutica Bayer,S.A.	Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
CA2500897A1 (en) *	2002-10-02	2004-04-15	Yeda Research And Development Co. Ltd.	Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
RU2270684C1 (ru) *	2005-01-20	2006-02-27	Анатолий Григорьевич Гриценко	Лекарственный препарат "витасорб"
WO2007014970A1 (es) *	2005-07-29	2007-02-08	Universidad De Barcelona	Composiciones farmacéuticas que comprenden una sal de tungsteno (vi) para el tratamiento de trastornos neurodegenerativos, en particular alzheimer y esquizofrenia
US20060100154A1 (en) *	2005-10-13	2006-05-11	Yeda Research And Development Co	Long-acting gonadotropin-releasing hormone analogs and methods of use thereof

2013
- 2013-01-22 ES ES201330071A patent/ES2478790B1/es active Active
2014
- 2014-01-21 PT PT147010672T patent/PT2948156T/pt unknown
- 2014-01-21 WO PCT/EP2014/051141 patent/WO2014114644A1/en not_active Ceased
- 2014-01-21 ES ES14701067.2T patent/ES2611776T3/es active Active
- 2014-01-21 HU HUE14701067A patent/HUE031910T2/en unknown
- 2014-01-21 HR HRP20161611TT patent/HRP20161611T1/hr unknown
- 2014-01-21 MX MX2015009364A patent/MX356851B/es active IP Right Grant
- 2014-01-21 CN CN201480016951.6A patent/CN105188721B/zh active Active
- 2014-01-21 PL PL14701067T patent/PL2948156T3/pl unknown
- 2014-01-21 CA CA2898953A patent/CA2898953C/en active Active
- 2014-01-21 EP EP14701067.2A patent/EP2948156B1/en active Active
- 2014-01-21 BR BR112015017483A patent/BR112015017483A2/pt not_active Application Discontinuation
- 2014-01-21 SI SI201430101A patent/SI2948156T1/sl unknown
- 2014-01-21 SG SG11201505701WA patent/SG11201505701WA/en unknown
- 2014-01-21 DK DK14701067.2T patent/DK2948156T3/da active
- 2014-01-21 AU AU2014209987A patent/AU2014209987B2/en active Active
- 2014-01-21 RU RU2015135578A patent/RU2635507C2/ru active
- 2014-01-21 KR KR1020157022529A patent/KR102182563B1/ko active Active
- 2014-01-21 RS RS20161000A patent/RS55418B1/sr unknown
- 2014-01-21 US US14/762,603 patent/US9675638B2/en active Active
- 2014-01-21 LT LTEP14701067.2T patent/LT2948156T/lt unknown
- 2014-01-21 SM SM20170018T patent/SMT201700018T1/it unknown
- 2014-01-21 NZ NZ710583A patent/NZ710583A/en unknown
- 2014-01-21 JP JP2015554128A patent/JP6045721B2/ja active Active
2015
- 2015-07-21 IL IL240062A patent/IL240062B/en active IP Right Grant
- 2015-07-22 CL CL2015002047A patent/CL2015002047A1/es unknown
2016
- 2016-11-24 CY CY20161101221T patent/CY1118287T1/el unknown
2017
- 2017-01-16 SM SM201700018T patent/SMT201700018B/it unknown

Also Published As

Publication number	Publication date
BR112015017483A2 (pt)	2017-07-11
RS55418B1 (sr)	2017-04-28
LT2948156T (lt)	2016-12-27
ES2478790B1 (es)	2015-05-06
KR20150130992A (ko)	2015-11-24
MX356851B (es)	2018-06-18
AU2014209987A1 (en)	2016-01-21
ES2478790A1 (es)	2014-07-22
EP2948156A1 (en)	2015-12-02
EP2948156B1 (en)	2016-10-26
US9675638B2 (en)	2017-06-13
CN105188721A (zh)	2015-12-23
CA2898953C (en)	2018-01-02
CN105188721B (zh)	2017-10-31
JP2016505057A (ja)	2016-02-18
SMT201700018B (it)	2017-03-08
IL240062B (en)	2018-11-29
IL240062A0 (en)	2015-09-24
HUE031910T2 (en)	2017-08-28
ES2611776T3 (es)	2017-05-10
PT2948156T (pt)	2016-11-30
SG11201505701WA (en)	2015-08-28
CL2015002047A1 (es)	2016-01-04
HK1217442A1 (en)	2017-01-13
CY1118287T1 (el)	2017-06-28
KR102182563B1 (ko)	2020-11-25
RU2015135578A (ru)	2017-03-02
HRP20161611T1 (hr)	2017-01-27
DK2948156T3 (da)	2017-01-02
MX2015009364A (es)	2016-03-08
CA2898953A1 (en)	2014-07-31
RU2635507C2 (ru)	2017-11-13
SI2948156T1 (sl)	2017-02-28
NZ710583A (en)	2016-06-24
US20150359820A1 (en)	2015-12-17
SMT201700018T1 (it)	2017-03-08
WO2014114644A1 (en)	2014-07-31
JP6045721B2 (ja)	2016-12-14
AU2014209987B2 (en)	2016-09-01

Publication	Publication Date	Title
HUE054783T2 (hu)	2021-09-28	Pridopidin Huntington-kór kezelésében
SG11202012656WA (en)	2021-01-28	Heterocyclic compounds useful in the treatment of disease
DK3022707T3 (da)	2020-01-20	Systemer og fremgangsmåder til at monitorere bevægelse af sygdomsfelt
EP3349854A4 (en)	2019-04-03	PREDICTING THE CLINICAL RESPONSE TO IL23 ANTAGONISTS WITH IL23 PATIENT BIOMARKERS
EP2964238A4 (en)	2016-09-07	ABCB5 (+) - STEM CELLS FOR THE TREATMENT OF EYE DISEASES
IL244492A0 (en)	2016-04-21	Broton tyrosine kinase inhibitors
EP2971141A4 (en)	2016-11-23	SYSTEMS AND METHODS FOR BIOLOGICAL ANALYSIS
HUE056006T2 (hu)	2022-01-28	Kombináció Parkinson-kór kezelésére
EP2965277A4 (en)	2016-08-10	PREDICTION OF APPROVAL OF TRANSACTIONS
UA29014S (uk)	2015-03-25	Комп'ютер
EP2976003A4 (en)	2016-12-14	METHOD AND TOOLS FOR ANALYZING BRAIN IMAGES
DK3089707T3 (da)	2021-10-11	Vævtransplantater og fremgangsmåder til fremstilling og brug af samme
EP2962216A4 (en)	2016-11-16	COMMON USE OF APPLICATION STATES
EP2983619A4 (en)	2016-10-05	SURGICAL GUIDANCE AND PLANNING SOFTWARE FOR SUITABILITY TREATMENT
EP2974879A4 (en)	2016-10-12	DISPLAY ELEMENT
EP3003140C0 (en)	2024-10-23	ELECTROCARDIOGRAM ANALYSIS
IL256206A (en)	2018-02-28	Mct4 inhibitors for treating disease
EP2982364A4 (en)	2016-03-16	OIL-IN-WATER EMULSION COMPOUND
FR3013056B1 (fr)	2018-01-19	Procede de preparation d'une graisse sulfonate de calcium complexe
GB201310150D0 (en)	2013-07-24	Methods and compositions relating to alzheimer's disease
EP3397146A4 (en)	2019-08-07	CARDIO-KINETIC CROSS-SPECTRAL DENSITY FOR THE EVALUATION OF SLEEP PHYSIOLOGY
ME02993B (me)	2018-10-20	Laktoferin za upotrebu u dijagnozi ili prognozi alchajmerove bolesтi
EP3331518A4 (en)	2019-04-03	COMBINATION THERAPY WITH ACAMPROSATE AND D-CYCLOSERIN
EP3027949A4 (en)	2016-12-21	4-round thread form
EP2991488A4 (en)	2016-12-21	GLYCOLIPID INHIBITION BY IMINO SUGAR